Inhibitor of angiotensin II type I receptors Eprosartan and Antiodarone as a combined treatment of advanced heart failure and atrial fibrillation

被引：3
|
作者：
Grigoryan, S.
Stepanyan, A. A.
Hazarapetyan, L. G.
机构：
[1] Inst Cardiol, Dept Arrhythmia, Yerevan, Armenia
[2] Cardiol Clin, Gjumri, Armenia
[3] NIH, Yerevan, Armenia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2007年 / 6卷
关键词：
D O I：
10.1016/S1567-4215(07)60421-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [21] Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock
    Hofmann, R
    Steinwender, C
    Kammler, J
    Kypta, A
    Wimmer, G
    Leisch, F
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (21-22) : 744 - 749
  • [22] Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock
    Mazhar, R.
    JOURNAL FUR KARDIOLOGIE, 2006, 13 : 14 - 14
  • [23] Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock
    Robert Hofmann
    Clemens Steinwender
    Jürgen Kammler
    Alex Kypta
    Gottfried Wimmer
    Franz Leisch
    Wiener klinische Wochenschrift, 2004, 116 : 744 - 749
  • [24] Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure - Role of kinins and angiotensin II type 2 receptors
    Liu, YH
    Yang, XP
    Sharov, VG
    Nass, O
    Sabbah, HN
    Peterson, E
    Carretero, OA
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08): : 1926 - 1935
  • [25] The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure
    Ermis, N.
    Ozhan, O.
    Ulutas, Z.
    Vardi, N.
    Colak, C.
    Parlakpinar, H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1318 - 1318
  • [26] Thromboembolic risk and related treatment in elderly patients with atrial fibrillation and advanced heart failure from rural areas
    Mateescu, A. D.
    Baluta, M. M.
    Vintila, M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S313 - S313
  • [27] Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure
    Carubelli, Valentina
    Lombardi, Carlo
    Specchia, Claudia
    Peveri, Giulia
    Oriecuia, Chiara
    Tomasoni, Daniela
    Di Pasquale, Mattia
    Inciardi, Riccardo
    Garrafa, Emirena
    Metra, Marco
    ESC HEART FAILURE, 2021, 8 (03): : 1944 - 1953
  • [28] Combined angiotensin II AT1 receptor blockade and angiotensin I-converting enzyme inhibition on survival in experimental heart failure
    Richer-Giudicelli, C.
    Fornes, P.
    Domergue, V.
    De Gasparo, M.
    Giudicelli, J. -F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 110 - 110
  • [29] Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure
    Nishio, Mayu
    Sakata, Yasushi
    Mano, Toshiaki
    Yoshida, Junichi
    Ohtani, Tomohito
    Takeda, Yasuharu
    Miwa, Takeshi
    Masuyama, Tohru
    Yamamoto, Kazuhiro
    Hori, Masatsugu
    JOURNAL OF HYPERTENSION, 2007, 25 (02) : 455 - 461
  • [30] ANGIOTENSIN CONVERTING ENZYME INHIBITOR REDUCES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS: A RETROSPECTIVE COHORT STUDY FROM THE TREATMENT OF PRESERVED CARDIAC FUNCTION HEART FAILURE WITH AN ALDOSTERONE ANTAGONIST TRIAL
    Tran Nguyen
    Alzahrani, Talal
    McCaffery, James
    Yunus, Raza
    Atanda, Adebayo
    Mercader, Marco
    Solomon, Allen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 519 - 519
12345